1.
J Investig Allergol Clin Immunol
; : 0, 2022 Dec 20.
Article
in English
| MEDLINE | ID: covidwho-2204501
2.
J Investig Allergol Clin Immunol
; 32(3): 218-220, 2022 06 20.
Article
in English
| MEDLINE | ID: covidwho-1904019
Subject(s)
COVID-19 , Drug Hypersensitivity , Skin Diseases , Antiviral Agents , Drug Hypersensitivity/diagnosis , Humans , SARS-CoV-2
3.
Allergy
; 76:199-199, 2021.
Article
in English
| Web of Science | ID: covidwho-1535713
4.
J Eur Acad Dermatol Venereol
; 35(7): e425-e427, 2021 Jul.
Article
in English
| MEDLINE | ID: covidwho-1158089
Subject(s)
COVID-19 Vaccines , COVID-19 , Arm , BNT162 Vaccine , Health Personnel , Humans , RNA, Messenger , SARS-CoV-2
5.
J Investig Allergol Clin Immunol
; 31(1): 89-91, 2021 Feb 17.
Article
in English
| MEDLINE | ID: covidwho-1006400
Subject(s)
COVID-19 Vaccines/therapeutic use , COVID-19/prevention & control , Hypersensitivity/therapy , Mass Vaccination , SARS-CoV-2/immunology , Vaccines, Synthetic/therapeutic use , BNT162 Vaccine , COVID-19/immunology , COVID-19/virology , COVID-19 Vaccines/adverse effects , Drug Hypersensitivity/immunology , Drug Hypersensitivity/prevention & control , Host-Pathogen Interactions , Humans , Hypersensitivity/diagnosis , Hypersensitivity/immunology , Immunocompromised Host , Mass Vaccination/adverse effects , Patient Safety , Risk Assessment , Risk Factors , Vaccines, Synthetic/adverse effects
6.
J Eur Acad Dermatol Venereol
; 34(11): e659-e662, 2020 Nov.
Article
in English
| MEDLINE | ID: covidwho-597075